These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1624024)

  • 21. Suppressive action of norethisterone enanthate and acetate on gonadotropin. (FSH and LH) levels. Radioimmunoassay in eugonadal and postmenopausal women.
    Franchimont P; Cession G; Ayalon D; Mutsers A; Legros JJ
    Obstet Gynecol; 1970 Jul; 36(1):93-100. PubMed ID: 5422095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Luteinizing hormone (LH) in hypergonadotropic hypogonadism].
    Jakowicki J; Putowski L; Jakimiuk A; Baranowski W
    Ginekol Pol; 2003 Jan; 74(1):7-11. PubMed ID: 12715431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
    de Kretser DM; Burger HG; Dumpys R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of aging on the hypothalamic-hypophyseal-gonadal axis in female rats.
    McPherson JC; Costoff A; Mahesh VB
    Fertil Steril; 1977 Dec; 28(12):1365-70. PubMed ID: 201506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Action of luteinizing hormone-releasing hormone (LH-RH) on gonadotropin secretion in normal subjects].
    Franchimont P; Becker H; Ernould C; Thys C; Demoulin A; Bourguignon JP; Legros JJ; Valcke JC
    Ann Endocrinol (Paris); 1973; 34(5):477-90. PubMed ID: 4603312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A gonadotropin and alpha-subunit suppression test for the assessment of the ectopic production of human chorionic gonadotropin and its subunits after the menopause.
    Papapetrou PD; Anagnostopoulos NI
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1187-95. PubMed ID: 3923023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophoretic and gel chromatographic analyses of follicle-stimulating hormone in human serum.
    Wide L
    Ups J Med Sci; 1981; 86(3):249-58. PubMed ID: 6798733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of pituitary gonadotropin release to gonadotropin releasing hormone/thyroid-stimulating hormone stimulation in women with systemic sclerosis.
    La Montagna G; Baruffo A; Pasquali D; Bellastella A; Tirri G; Sinisi AA
    Rheumatology (Oxford); 2001 Mar; 40(3):310-4. PubMed ID: 11285379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men.
    Wide L; Naessén T; Sundström-Poromaa I; Eriksson K
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4410-7. PubMed ID: 17711919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
    Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis.
    Padmanabhan V; Lang LL; Sonstein J; Kelch RP; Beitins IZ
    J Clin Endocrinol Metab; 1988 Sep; 67(3):465-73. PubMed ID: 3137241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
    Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
    J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure.
    Welt CK; Hall JE; Adams JM; Taylor AE
    J Clin Endocrinol Metab; 2005 Feb; 90(2):826-30. PubMed ID: 15562017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studies.
    Mortola JF; Sathanandan M; Pavlou S; Dahl KD; Hsueh AJ; Rivier J; Vale W; Yen SS
    Fertil Steril; 1989 Jun; 51(6):957-63. PubMed ID: 2498133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase.
    Wide L; Bakos O
    J Clin Endocrinol Metab; 1993 Apr; 76(4):885-9. PubMed ID: 8473400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous Recovery of Ovarian Function in an Adolescent with Galactosemia and Apparent Premature Ovarian Insufficiency.
    Davies P; Connor E; MacKenzie J; Jamieson MA
    J Pediatr Adolesc Gynecol; 2015 Aug; 28(4):e101-3. PubMed ID: 26024933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.